In March 2026, The OvaCure Collection proudly hosted three young talents at the BRIC facility, University of Copenhagen for intensive hands-on training in organoid culturing.
Elisa Yaniz, (post-doctoral fellow, Gustave Roussy), Audrey Le Formal (research technician, Gustave Roussy), and Cedric Patrice Moser (trainee, University of Basel), spent several productive days learning and practicing state-of-the-art organoid protocols under the guidance of Assistant Professor Wojciech Senkowski.
Elisa Yaniz reflected on the visit: “Our visit to BRIC was very productive thanks to Wojciech, who was extremely helpful and patient, teaching us the organoid established protocol step by step, including every detail and trick. Cedric, Audrey, and I also had the opportunity to practice by ourselves, facing the difficulties and tricky steps on our own. It has been a very rewarding experience, and we are especially grateful to Wojciech!”
The visit was part of The Precision-ec Project, the winning project from The OvaCure Innovation Challenge 2025. Jointly involving Prof. Alexandra Leary (Gustave Roussy), Prof. Francis Jacob (University of Basel), Prof. James Brenton (University of Cambridge) and Prof. Birgitte Regenberg (University of Copenhagen). Part of the project aims to use the organoid cultures from The OvaCure Collection, thus handling these organoids and growing new cultures from Swiss ovarian cancer patients is an essential part of the project.
By combining top-quality tissue samples, expert training, and collaborative research, The Precision-ec Project is poised to generate valuable insights that could improve treatment selection for patients with HRP-HGSOC and inform smarter clinical trials in the future.
Moreover, the successful visit of Audrey, Elisa, and Cedric exemplifies the power of collaboration and training in advancing biomedical research. It is a step forward not only for The Precision-ec Project but also for the OvaCure Collection’s broader goal of making organoid technology accessible to scientists worldwide to advance promising research in ovarian cancer.
